89 related articles for article (PubMed ID: 2945090)
1. Antimalarial activity of selected aromatic chelators. IV. Cation uptake by Plasmodium falciparum in the presence of oxines and siderochromes.
Scheibel LW; Stanton GG
Mol Pharmacol; 1986 Oct; 30(4):364-9. PubMed ID: 2945090
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial activity of selected aromatic chelators V. Localization of 59Fe in Plasmodium falciparum in the presence of oxines.
Scheibel LW; Rodriguez S
Prog Clin Biol Res; 1989; 313():119-49. PubMed ID: 2506579
[No Abstract] [Full Text] [Related]
3. Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring.
Scheibel LW; Adler A
Mol Pharmacol; 1982 Jul; 22(1):140-4. PubMed ID: 6811856
[No Abstract] [Full Text] [Related]
4. Antimalarial activity of selected aromatic chelators.
Scheibel LW; Adler A
Mol Pharmacol; 1980 Sep; 18(2):320-5. PubMed ID: 6775184
[No Abstract] [Full Text] [Related]
5. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
6. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
[TBL] [Abstract][Full Text] [Related]
7. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
Pattanapanyasat K; Kotipun K; Yongvanitchit K; Hider RC; Kyle DE; Heppner DG; Walsh DS
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):64-9. PubMed ID: 11485097
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum: the fungal metabolite gliotoxin inhibits proteasome proteolytic activity and exerts a plasmodicidal effect on P. falciparum.
Hatabu T; Hagiwara M; Taguchi N; Kiyozawa M; Suzuki M; Kano S; Sato K
Exp Parasitol; 2006 Mar; 112(3):179-83. PubMed ID: 16384554
[TBL] [Abstract][Full Text] [Related]
9. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators.
Loyevsky M; John C; Dickens B; Hu V; Miller JH; Gordeuk VR
Mol Biochem Parasitol; 1999 Jun; 101(1-2):43-59. PubMed ID: 10413042
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial action of hydrophilic drugs: involvement of aqueous access routes to intracellular parasites.
Loyevsky M; Cabantchik ZI
Mol Pharmacol; 1994 Mar; 45(3):446-52. PubMed ID: 8145731
[TBL] [Abstract][Full Text] [Related]
11. [Iron chelation in antimalarial therapy].
Pradines B; Millet J; Henry M
Med Trop (Mars); 2003; 63(2):119-30. PubMed ID: 12910648
[TBL] [Abstract][Full Text] [Related]
12. Reversed siderophores act as antimalarial agents.
Shanzer A; Libman J; Lytton SD; Glickstein H; Cabantchik ZI
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6585-9. PubMed ID: 1862083
[TBL] [Abstract][Full Text] [Related]
13. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
Richardson D; Ponka P; Baker E
Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
[TBL] [Abstract][Full Text] [Related]
14. Iron chelators: mode of action as antimalarials.
Cabantchik ZI; Glickstein H; Golenser J; Loyevsky M; Tsafack A
Acta Haematol; 1996; 95(1):70-7. PubMed ID: 8604590
[TBL] [Abstract][Full Text] [Related]
15. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
Dehkordi LS; Liu ZD; Hider RC
Eur J Med Chem; 2008 May; 43(5):1035-47. PubMed ID: 17869385
[TBL] [Abstract][Full Text] [Related]
16. In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum.
Biswas S
J Postgrad Med; 2001; 47(4):240-3. PubMed ID: 11832638
[TBL] [Abstract][Full Text] [Related]
17. Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection.
Fritsche G; Larcher C; Schennach H; Weiss G
J Infect Dis; 2001 May; 183(9):1388-94. PubMed ID: 11294671
[TBL] [Abstract][Full Text] [Related]
18. Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin.
Kuhn Y; Rohrbach P; Lanzer M
Cell Microbiol; 2007 Apr; 9(4):1004-13. PubMed ID: 17381432
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
[TBL] [Abstract][Full Text] [Related]
20. Developmental-stage-specific triacylglycerol biosynthesis, degradation and trafficking as lipid bodies in Plasmodium falciparum-infected erythrocytes.
Palacpac NM; Hiramine Y; Mi-ichi F; Torii M; Kita K; Hiramatsu R; Horii T; Mitamura T
J Cell Sci; 2004 Mar; 117(Pt 8):1469-80. PubMed ID: 15020675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
